Sign Out
Use in Pregnancy: Adequate and well-controlled studies in pregnant women have not been reported; however, carboplatin has been shown to be embryotoxic and teratogenic in rats. In the event the drug has been used in a pregnant patient, or if the patient becomes pregnant while on treatment with carboplatin she should be apprised of the potential hazard to the fetus. Women of childbearing potential should be advised to avoid becoming pregnant.
Use in Breastfeeding: It is not known whether carboplatin is excreted in breast milk. To avoid possible harmful effects in the infant, breastfeeding is not advised during carboplatin therapy.
Continue with Google